OncoHost to Present Plasma Proteomics Research at ISLB 2026
The research concerns early detection of immunotherapy resistance; new data indicates longitudinal plasma proteomics may detect disease progression.
The research concerns early detection of immunotherapy resistance; new data indicates longitudinal plasma proteomics may detect disease progression.